Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl- amides for prostate cancer

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 21, 2004, Pages 5289-5293

  Gududuru, Veeresa ^a   Hurh, Eunju ^b   Dalton, James T ^b   Miller, Duane D ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antiproliferative effect; Lysophosphatidic acid; Phosphate mimics; Prostate cancer; Thiazolidinones

Indexed keywords

AMIDE; THIAZOLIDINE DERIVATIVE;

APOPTOSIS; CANCER CELL CULTURE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

AMIDES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; PROSTATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 5344259691     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.08.029     Document Type: Conference Paper

References (19)

1. American Cancer Society Cancer Facts and Figures 2003 American Cancer Society Atlanta, GA
2. American Cancer Society: Cancer Facts and Figures, 2004
3. M. Quinn, and P. Babb BJU Int. 90 2002 162
4. H. Gronberg Lancet 361 2003 859
5. C.S. Foster, D.G. Bostwick, H. Bonkhoff, J.E. Damber, T. van der Kwast, R. Montironi, and W.A. Sakr Scand. J. Urol. Nephrol. 205 2000 19
6. D.B. Agus, C. Cordon-Cardo, W. Fox, M. Drobnjak, A. Koff, D.W. Golde, and H.I. Scher J. Natl. Cancer. Inst. 91 1999 1869
7. D. Djakiew Prostate 42 2000 150
8. M. Frydenberg, P.D. Stricker, and K.W. Kaye Lancet 349 1997 1681
9. A. Beedassy, and G. Cardi Sem. Oncol. 26 1999 428
10. D. Raghavan, B. Koczwara, and M. Javis Eur. J. Cancer 33 1997 566
11. V. Gududuru, E. Hurh, G.G. Durgam, S.S. Hong, V.M. ; Sardar, H. Xu, J.T. Dalton, and D.D. Miller Bioorg. Med. Chem. Lett. 14 2004 4919
12. R. Jasinska, Q.X. Zhang, C. Pilquil, I. Singh, J. Xu, J. Dewald, D.A. Dillon, L.G. Berthiaume, G.M. Carman, D.W. Waggoner, and D.N. Brindley Biochem. J. 340 1999 677
13. J. Xu, L.M. Love, I. Singh, Q.X. Zhang, J. Dewald, D.A. Wang, D.J. Fischer, G. Tigyi, L.G. Berthiaume, D.W. Waggoner, and D.N. Brindley J. Biol. Chem. 275 2000 27520
14. S.B. Hooks, W.L. Santos, D.S. Im, C.E. Heise, T.L. Macdonald, and K.R. Lynch J. Biol. Chem. 276 2001 4611
15. C.J. Andres, J.J. Bronson, S.V. D'Andrea, M.S. Deshpande, P.J. Falk, K.A. Young, W.E. Harte, H.T. Ho, P.F. Misco, J.G. Robertson, D. Stock, Y. Sun, and A.W. Walsh Bioorg. Med. Chem. Lett. 10 2000 715
16. C.P. Homes, J.P. Chinn, C.G. Look, E.M. Gordon, and M.A. Gallop J. Org. Chem. 60 1995 7328
17. A.C. Schuemacher, and R.W. Hoffman Synthesis 22 2001 243
18. 4S: C, 66.88; H, 9.29; N, 5.38. Found: C, 66.68; H, 9.27; N, 5.41
19. 50 (i.e., concentration that inhibited cell growth by 50% of untreated control) values were obtained by nonlinear regression analysis using WinNonlin